Crassociates, Inc.

Crassociates, Inc., a Dallas-based large business healthcare services contractor operating under parent Robbins Group, Inc., delivers community-based outpatient clinic establishment, staffing, and operations to the Department of Veterans Affairs across multiple Veterans Integrated Service Networks as a prime contractor (100% of recent awards). The company competes full-and-open with no set-aside designations and operates through a named subsidiary, Medmark Veteran Services LLC, to manage concurrent clinic operations nationwide.

Crassociates' customer concentration is nearly total within the VA system. The top five funding entities by award count and potential value include VISN 16, VISN 17, VISN 2, VISN 22, and the Army Medical Command, collectively representing the vast majority of recent activity. VISN 17 leads by combined potential value at $302.3 million across 111 awards, while VISN 16 places second at $299.6 million across 142 awards. This concentration reflects Crassociates' specialization in VA-exclusive healthcare delivery: the company holds twelve active single-award indefinite delivery contracts across multiple VISNs, with ceiling values ranging from $1.6 million to $13.6 million, and service locations spanning Mississippi, California, Texas, Utah, Pennsylvania, New York, and Florida. All recent awards carry firm fixed-price terms and carry no small business set-aside.

Representative primary contract work includes a $13.62 million IDC with VISN 16 for Columbus CBOC services (base April 2022 through March 2027 with four one-year options, currently executing Option Year 4 with a $2.73 million delivery order as of April 2026); an $11.68 million IDC with VISN 22 for Escondido CBOC operations in San Diego, California (through August 2025); a $2.01 million single-award IDC with VISN 19 for Roosevelt CBOC services in Roosevelt, Utah (January through December 2026); and facility support contracts with VISN 4 for occupancy and primary care services in Pennsylvania. Delivery orders under these IDCs fund interim and ongoing clinic operations, primary care, mental health support, pharmacy, laboratory, and occupational therapy services.

Activity has declined over the past four years. Awards per year fell from 19 in 2022 to 5 in 2026 (most recent data through May 1, 2026). The vendor's overall award portfolio totals 1,516 prime awards with combined potential value of $1.56 billion and combined dollars obligated of $1.03 billion (66% of potential value). With only five awards showing ultimate completion within the next twenty-four months (combined potential value $7.1 million), recompete exposure is minimal in the near term, but the year-over-year activity decline signals tightening VA procurement or consolidation of awards to fewer contractors.

SCI-reported invoicing shows a smaller federal services footprint: $1.3 million across 176 FTEs in FY2022, declining to $404 thousand across 99.8 FTEs by FY2024. Government-paid hourly rates on SCI-reportable prime contracts ran low—median $3.18/hr, with a 90th percentile of $3.86/hr—reflecting the nature of community clinic staffing work; the 10th percentile of $1.62/hr suggests a significant volume of lower-cost support labor. Crassociates performs all SCI-reportable work directly with no named subcontractor engagement.

The company's capability portfolio is narrow and specialized: the entire award history and NAICS concentration (563 awards under "Offices of Physicians," 478 under "All Other Outpatient Care Centers") center on VA clinic operations and medical staffing. Unlike larger federal contractors, Crassociates does not carry positions on government-wide acquisition contracts, GSA schedules, or multi-agency IDIQs; all work flows through direct single-award IDCs with individual VISNs. This singular focus on VA healthcare delivery, combined with declining recent award volume, positions Crassociates as a stable but narrow-spectrum operator in the VA ecosystem rather than a diversified federal healthcare prime.